ARTICLE | Company News
Rigel, Daiichi Pharmaceutical deal
January 13, 2003 8:00 AM UTC
RIGL received an undisclosed milestone from Daiichi under a 2002 deal to research protein degradation to develop cancer therapeutics (see BioCentury, Aug. 19, 2002). The payment was triggered by advan...